Haleon (LON:HLN) Stock Price Down 1.1% – Here’s Why

Shares of Haleon plc (LON:HLN) dropped 1.1% during trading on Tuesday . The stock traded as low as GBX 374.50 ($4.86) and last traded at GBX 374.50 ($4.86). Approximately 10,110,692 shares changed hands during trading, a decline of 49% from the average daily volume of 19,871,000 shares. The stock had previously closed at GBX 378.50 ($4.91).

Analysts Set New Price Targets

Separately, Berenberg Bank lifted their price target on shares of Haleon from GBX 410 ($5.32) to GBX 447 ($5.80) and gave the company a “buy” rating in a research report on Monday, August 5th.

Haleon Trading Down 1.1 %

The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 54.18. The company has a 50-day moving average price of GBX 384.37 and a 200-day moving average price of GBX 352.55. The company has a market capitalization of £33.85 billion, a price-to-earnings ratio of 3,120.83, a P/E/G ratio of 1.49 and a beta of 0.19.

Haleon Cuts Dividend

The firm also recently announced a dividend, which was paid on Thursday, September 19th. Shareholders of record on Thursday, August 15th were issued a GBX 2 ($0.03) dividend. This represents a yield of 0.57%. The ex-dividend date was Thursday, August 15th. Haleon’s dividend payout ratio (DPR) is currently 5,000.00%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.